.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Predict branded drug patent expiration
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
Cipla
Express Scripts
Cantor Fitzgerald
UBS
Cerilliant
McKesson
Baxter
Accenture
Chubb

Generated: June 22, 2017

DrugPatentWatch Database Preview

REZIPAS Drug Profile

« Back to Dashboard

What is the patent landscape for Rezipas, and when can generic versions of Rezipas launch?

Rezipas is a drug marketed by Bristol Myers Squibb and is included in one NDA.

The generic ingredient in REZIPAS is aminosalicylic acid resin complex. There are fifteen drug master file entries for this compound. Additional details are available on the aminosalicylic acid resin complex profile page.

Summary for Tradename: REZIPAS

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list84
Patent Applications: see list5,502
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:REZIPAS at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers Squibb
REZIPAS
aminosalicylic acid resin complex
POWDER;ORAL009052-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Federal Trade Commission
Chinese Patent Office
Moodys
Baxter
Colorcon
Fish and Richardson
Dow
Harvard Business School
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot